elicera.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Elicera Therapeutics |
| Description | Fighting cancer with next generation armed cell and gene Elicera Therapeutics develops cell and gene therapies in |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 99.83.190.102 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
elicera.com Valuation
|
US$978,538
Last updated: 2023-05-17 09:20:24
elicera.com has Semrush global rank of 10,816,453. elicera.com has an estimated worth of US$ 978,538, based on its estimated Ads revenue. elicera.com receives approximately 112,909 unique visitors each day. Its web server is located in United States, with IP address 99.83.190.102. According to SiteAdvisor, elicera.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$978,538 |
| Daily Ads Revenue | US$904 |
| Monthly Ads Revenue | US$27,098 |
| Yearly Ads Revenue | US$325,176 |
| Daily Unique Visitors | 7,528 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| elicera.com. | A | 3599 | IP: 99.83.190.102 |
| elicera.com. | A | 3599 | IP: 75.2.70.75 |
| elicera.com. | NS | 3600 | NS Record: ns2.loopia.se. |
| elicera.com. | NS | 3600 | NS Record: ns1.loopia.se. |
| elicera.com. | MX | 3600 | MX Record: 10 mailcluster.loopia.se. |
| elicera.com. | MX | 3600 | MX Record: 20 mail2.loopia.se. |
HtmlToTextCheckTime:2023-05-17 09:20:24
| en / sv About Elicera Elicera in brief Board Team Advisors Elicera’s history Immuno-oncology What is immuno-oncology? Oncolytic virus CAR T-cell therapy Technology CAR T-cell therapy Challenges Mode-of-action Scientific publications Pipeline Pipeline ELC-100 ELC-201 ELC-301 ELC-401 Clinical trials Patent portfolio Investors Press Releases Corporate Governance The Share Financial Reports Financial Calendar Events IPO Analyst Coverage News News Press Releases Events Contact Fighting cancer with next generation armed cell and gene therapies Technology Investors News & Press Releases May 16, 2023 Regulatory Press Release Press Release News Elicera Therapeutics AB (publ) Interim Report 1 January – 31 March 2023 Read more April 28, 2023 Regulatory Press Release Press Release News Elicera Therapeutics receives conditional approval from the Medical Products Agency on its CAR T-cell Clinical Trial Application to test ELC-301 (CARMA-study) Read more April 17, 2023 Regulatory Press Release Press |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty Date: Wed, 16 Mar 2022 09:47:01 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://elicera.com/ HTTP/2 301 server: openresty date: Wed, 16 Mar 2022 09:47:01 GMT content-type: text/html content-length: 166 location: https://www.elicera.com/ HTTP/2 200 server: openresty date: Wed, 16 Mar 2022 09:47:02 GMT content-type: text/html content-length: 27035 x-lambda-id: 61b0c4da-f357-4f05-8eb9-4dfbe692ca69 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 11718 x-served-by: cache-iad-kcgs7200109-IAD, cache-dub4348-DUB x-cache: HIT, MISS x-cache-hits: 1, 0 x-timer: S1647424022.257739,VS0,VE86 vary: x-wf-forwarded-proto, Accept-Encoding x-cluster-name: eu-west-1-prod-eks-15 |
elicera.com Whois Information
Domain Name: ELICERA.COM Registry Domain ID: 2463536791_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ascio.com Registrar URL: http://www.ascio.com Updated Date: 2021-11-20T11:15:25Z Creation Date: 2019-12-05T07:40:44Z Registry Expiry Date: 2022-12-05T07:40:44Z Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA Registrar IANA ID: 106 Registrar Abuse Contact Email: abuse@ascio.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.LOOPIA.SE Name Server: NS2.LOOPIA.SE DNSSEC: unsigned >>> Last update of whois database: 2022-03-16T10:50:37Z <<< |